Research
-
Personalized Structural Biology aids cancer treatment decisions
Cancer specialists at Vanderbilt University Medical Center, in partnership with biochemists and structural biologists across the Vanderbilt University campus, are taking “personalized” cancer therapy to a new level. Read MoreApr 8, 2021
-
Study revises understanding of cancer metabolism
Tumors consume glucose at high rates, but a team of Vanderbilt researchers has discovered that cancer cells themselves are not the culprit, upending models of cancer metabolism that have been developed and refined over the last 100 years. Read MoreApr 7, 2021
-
Genetic differences in Wilms tumor
Unique somatic gene mutations may contribute to racial disparities in the incidence of Wilms tumor — the most common childhood kidney cancer. Read MoreApr 6, 2021
-
Codeine metabolizer status in clinical practice
Vanderbilt researchers have developed a response score using genetic and clinical information to aid prescribing of the widely used pain medication codeine. Read MoreApr 5, 2021
-
COVID-19 met with intensive teamwork
Team members serving COVID-19 inpatients were more densely connected, interacting far more than their medical ICU counterparts. Read MoreApr 1, 2021
-
Novel way to neutralize Rift Valley Fever Virus
The discovery of monoclonal antibodies that neutralize Rift Valley Fever Virus — an emerging infection with pandemic potential — lays the foundation for future therapeutic antibody development. Read MoreApr 1, 2021
-
Study shows new COVID target could improve vaccines
Despite an impressive vaccination effort that exceeds 2 million shots a day, rates of COVID-19 are again on the rise in several parts of the United States, as is the spread of highly transmissible variants of the virus. Read MoreApr 1, 2021
-
Physician-scientists Aliyu, Tindle elected to ASCI
Vanderbilt’s Muktar Aliyu, MBBS, MPH, DrPH, and Hilary Tindle, MD, MPH, will be inducted this year into the American Society for Clinical Investigation (ASCI), an elite honor society of physician-scientists from the upper ranks of academic medicine and industry. Read MoreMar 31, 2021
-
NYU’s Tsien to discuss brain plasticity at next Discovery Lecture
Richard Tsien, PhD, director of the Neuroscience Institute at NYU Langone Medical Center, will deliver the next web-based Discovery Lecture. Read MoreMar 29, 2021
-
Research Snapshot: Exosuit concept developed at Vanderbilt peeks at the future of wearable tech
The idea Karl Zelik (Vanderbilt University) Erik Lamers (Vanderbilt University) Karl E. Zelik, assistant professor of mechanical engineering, and recent Ph.D. graduate Erik P. Lamers revealed a new exosuit designed to bring back relief to workers who have been under high strain throughout the pandemic, including last-mile delivery drivers and essential workers. The suit can... Read MoreMar 25, 2021
-
Team studies new use for pulmonary hypertension drug
An FDA-approved medication enhances the function of T regulatory cells (Treg), a class of immune cells that restrains the immune response, Vanderbilt investigators have discovered. Read MoreMar 25, 2021
-
Prostate cancer microenvironment
Distinct cancer-associated fibroblasts in the prostate tumor microenvironment may influence tumor progression and could point to new therapeutic targets. Read MoreMar 23, 2021
-
Chemo for cancer lowers dementia risk
Cancer chemotherapy lowered risk of Alzheimer’s disease and other neurocognitive disorders that disproportionately affect older people. Read MoreMar 22, 2021
-
Akard appointed to lead PhD in Nursing Science program
Associate Professor Terrah Foster Akard, PhD’08, MSN’01, FAAN, has been named director of the PhD in Nursing Science program at Vanderbilt University School of Nursing. Read MoreMar 20, 2021
-
Strength training for osteoarthritis
High-intensity strength training is not more effective than low-intensity training or educational efforts for reducing knee pain in patients with osteoarthritis. Read MoreMar 18, 2021
-
HIV, diabetes and immune cells in fat
In HIV-positive individuals with diabetes, immune cells in fat are more proinflammatory and cytotoxic and may represent a therapeutic target for diabetes. Read MoreMar 18, 2021
-
Study to assess allergic reactions to COVID vaccines
Vanderbilt University Medical Center is recruiting volunteers for a randomized controlled phase 2 clinical trial to help determine the prevalence of systemic allergic reactions (SARS) to the two-dose COVID-19 mRNA vaccines made by Pfizer-BioNTech and Moderna. Read MoreMar 18, 2021
-
Vanderbilt research played key role in new lung screen guidelines
The U.S. Preventive Services Task Force (USPSTF) has formally recommended two changes that will nearly double the number of people eligible for lung cancer screening by lowering the age from 55 to 50 and reducing the number of smoking history pack years from 30 to 20. Read MoreMar 18, 2021
-
Artificial intelligence calculates suicide attempt risk at VUMC
A machine learning algorithm that predicts suicide attempt recently underwent a prospective trial at the institution where it was developed, Vanderbilt University Medical Center. Read MoreMar 15, 2021
-
2021 summer session details announced
Vanderbilt University has announced details about summer session, including information about online courses, experiential learning and in-person research, and residential housing. Read MoreMar 12, 2021